Literature DB >> 128305

Brain and spinal cord lesions in pigs inoculated with swine vesicular disease (UKG strain) virus and coxsackievirus B5.

V S Monlux, P D McKercher, J H Graves.   

Abstract

Pigs inoculated intravenously with swine vesicular disease virus (UKG strain), those inoculated with coxsackievirus B5, and other pigs exposed by pen contact to the same viruses developed diffuse encephalomyelitis. Perivascular cuffing, with lymphocytes and formation of neuroglia cell foci, were most prominent in telencephalon, diencephalon, and mesencephalon. Encephalitis was of mild to severe intensity. Severity of lesions was more extensive and severe in the pigs exposed to swine vesicular disease virus. Pen contact exposure to either of the 2 viruses caused a more severe central nervous system reaction than did intravenous inoculation. The type and the distribution of lesions produced by the 2 viruses indicate that they may be related.

Entities:  

Mesh:

Year:  1975        PMID: 128305

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  6 in total

1.  Experimental swine vesicular disease, pathology and immunofluorescence studies.

Authors:  R M Chu; D M Moore; J D Conroy
Journal:  Can J Comp Med       Date:  1979-01

2.  Virus isolation studies in an outbreak of porcine encephalomyelitis.

Authors:  J A Lynch; B D Binnington; D M Hoover
Journal:  Can J Comp Med       Date:  1984-04

3.  Detection of swine caliciviruses by indirect immunofluorescence.

Authors:  F W Wilder
Journal:  Can J Comp Med       Date:  1980-01

4.  Swine vesicular disease in Great Britain.

Authors:  W A Watson
Journal:  Can Vet J       Date:  1981-06       Impact factor: 1.008

5.  A comparative electrophoretic examination of swine vesicular disease virus and Coxsackie B5 virus.

Authors:  K J Sorensen
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

6.  Coxsackievirus-cell interactions that initiate infection in porcine ileal explants.

Authors:  B A Heinz; D O Cliver
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.